- Home
- HRMY vs ESRT Comparison
HRMY vs ESRT Comparison
Compare HRMY & ESRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- ESRT
- Stock Information
- Founded
- HRMY 2017
- ESRT 2011
- Country
- HRMY United States
- ESRT United States
- Employees
- HRMY N/A
- ESRT N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- ESRT Real Estate Investment Trusts
- Sector
- HRMY Health Care
- ESRT Real Estate
- Exchange
- HRMY Nasdaq
- ESRT Nasdaq
- Market Cap
- HRMY 1.8B
- ESRT 1.2B
- IPO Year
- HRMY 2020
- ESRT 2013
- Fundamental
- Price
- HRMY $34.00
- ESRT $8.23
- Analyst Decision
- HRMY Strong Buy
- ESRT Hold
- Analyst Count
- HRMY 9
- ESRT 2
- Target Price
- HRMY $54.44
- ESRT $10.65
- AVG Volume (30 Days)
- HRMY 642.5K
- ESRT 2.3M
- Earning Date
- HRMY 08-05-2025
- ESRT 07-23-2025
- Dividend Yield
- HRMY N/A
- ESRT 1.70%
- EPS Growth
- HRMY 13.13
- ESRT 2.67
- EPS
- HRMY 2.62
- ESRT 0.30
- Revenue
- HRMY $744,852,000.00
- ESRT $762,039,000.00
- Revenue This Year
- HRMY $20.10
- ESRT $3.70
- Revenue Next Year
- HRMY $18.01
- ESRT $2.56
- P/E Ratio
- HRMY $13.10
- ESRT $27.18
- Revenue Growth
- HRMY 20.62
- ESRT 0.78
- 52 Week Low
- HRMY $26.47
- ESRT $6.56
- 52 Week High
- HRMY $41.61
- ESRT $11.62
- Technical
- Relative Strength Index (RSI)
- HRMY 58.91
- ESRT 51.02
- Support Level
- HRMY $31.70
- ESRT $7.98
- Resistance Level
- HRMY $35.08
- ESRT $8.28
- Average True Range (ATR)
- HRMY 0.95
- ESRT 0.28
- MACD
- HRMY 0.27
- ESRT -0.03
- Stochastic Oscillator
- HRMY 71.80
- ESRT 55.12
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About ESRT Empire State Realty Trust Inc.
Empire State Realty Trust operates as a pure-play greater New York and Manhattan-focused REIT, featuring its landmark Empire State Building office and observation deck. The company owns and operates around 8.5 million square feet of office space, about 80% of which is located in Manhattan.